Global Drug-Eluting Bioabsorbable Stents Sales Market Report 2024
The global Drug-Eluting Bioabsorbable Stents market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Drug-Eluting Bioabsorbable Stents market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by region (country), by Type and by Application for the period 2016-2027.
Segment by Type
Serolimus and Paclitaxel Drug-Eluting Stents
Sirolimus Drug Eluting Stents
Segment by Application
Coronary Artery Diseases
Peripheral Artery Diseases
The Drug-Eluting Bioabsorbable Stents market is analysed and market size information is provided by regions (countries).
Segment by Application
, the Drug-Eluting Bioabsorbable Stents market is segmented into North America, Europe, China, Japan, Southeast Asia, India and Other Regions.
By Company
Medtronic
B.Braun Melsungen
Abbott Laboratories
Boston Scientific Corporation
Biosensors International
Terumo Corporation.
MicroPort Scientific Corporation
Alvimedica
Biotronik
Elixir Medical Corporation
Innovative Health Technologies
Table of Content
1 Drug-Eluting Bioabsorbable Stents Market Overview
1.1 Drug-Eluting Bioabsorbable Stents Product Scope
1.2 Drug-Eluting Bioabsorbable Stents Segment by Type
1.2.1 Global Drug-Eluting Bioabsorbable Stents Sales by Type (2016 & 2021 & 2027)
1.2.2 Serolimus and Paclitaxel Drug-Eluting Stents
1.2.3 Sirolimus Drug Eluting Stents
1.3 Drug-Eluting Bioabsorbable Stents Segment by Application
1.3.1 Global Drug-Eluting Bioabsorbable Stents Sales Comparison by Application (2016 & 2021 & 2027)
1.3.2 Coronary Artery Diseases
1.3.3 Peripheral Artery Diseases
1.4 Drug-Eluting Bioabsorbable Stents Market Estimates and Forecasts (2016-2027)
1.4.1 Global Drug-Eluting Bioabsorbable Stents Market Size in Value Growth Rate (2016-2027)
1.4.2 Global Drug-Eluting Bioabsorbable Stents Market Size in Volume Growth Rate (2016-2027)
1.4.3 Global Drug-Eluting Bioabsorbable Stents Price Trends (2016-2027)
2 Drug-Eluting Bioabsorbable Stents Estimates and Forecasts by Region
2.1 Global Drug-Eluting Bioabsorbable Stents Market Size by Region: 2016 VS 2021 VS 2027
2.2 Global Drug-Eluting Bioabsorbable Stents Retrospective Market Scenario by Region (2016-2021)
2.2.1 Global Drug-Eluting Bioabsorbable Stents Sales Market Share by Region (2016-2021)
2.2.2 Global Drug-Eluting Bioabsorbable Stents Revenue Market Share by Region (2016-2021)
2.3 Global Drug-Eluting Bioabsorbable Stents Market Estimates and Forecasts by Region (2022-2027)
2.3.1 Global Drug-Eluting Bioabsorbable Stents Sales Estimates and Forecasts by Region (2022-2027)
2.3.2 Global Drug-Eluting Bioabsorbable Stents Revenue Forecast by Region (2022-2027)
2.4 Geographic Market Analysis: Market Facts & Figures
2.4.1 North America Drug-Eluting Bioabsorbable Stents Estimates and Projections (2016-2027)
2.4.2 Europe Drug-Eluting Bioabsorbable Stents Estimates and Projections (2016-2027)
2.4.3 China Drug-Eluting Bioabsorbable Stents Estimates and Projections (2016-2027)
2.4.4 Japan Drug-Eluting Bioabsorbable Stents Estimates and Projections (2016-2027)
2.4.5 Southeast Asia Drug-Eluting Bioabsorbable Stents Estimates and Projections (2016-2027)
2.4.6 India Drug-Eluting Bioabsorbable Stents Estimates and Projections (2016-2027)
3 Global Drug-Eluting Bioabsorbable Stents Competition Landscape by Players
3.1 Global Top Drug-Eluting Bioabsorbable Stents Players by Sales (2016-2021)
3.2 Global Top Drug-Eluting Bioabsorbable Stents Players by Revenue (2016-2021)
3.3 Global Drug-Eluting Bioabsorbable Stents Market Share by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Drug-Eluting Bioabsorbable Stents as of 2020)
3.4 Global Drug-Eluting Bioabsorbable Stents Average Price by Company (2016-2021)
3.5 Manufacturers Drug-Eluting Bioabsorbable Stents Manufacturing Sites, Area Served, Product Type
3.6 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Global Drug-Eluting Bioabsorbable Stents Market Size by Type
4.1 Global Drug-Eluting Bioabsorbable Stents Historic Market Review by Type (2016-2021)
4.1.1 Global Drug-Eluting Bioabsorbable Stents Sales Market Share by Type (2016-2021)
4.1.2 Global Drug-Eluting Bioabsorbable Stents Revenue Market Share by Type (2016-2021)
4.1.3 Global Drug-Eluting Bioabsorbable Stents Price by Type (2016-2021)
4.2 Global Drug-Eluting Bioabsorbable Stents Market Estimates and Forecasts by Type (2022-2027)
4.2.1 Global Drug-Eluting Bioabsorbable Stents Sales Forecast by Type (2022-2027)
4.2.2 Global Drug-Eluting Bioabsorbable Stents Revenue Forecast by Type (2022-2027)
4.2.3 Global Drug-Eluting Bioabsorbable Stents Price Forecast by Type (2022-2027)
5 Global Drug-Eluting Bioabsorbable Stents Market Size by Application
5.1 Global Drug-Eluting Bioabsorbable Stents Historic Market Review by Application (2016-2021)
5.1.1 Global Drug-Eluting Bioabsorbable Stents Sales Market Share by Application (2016-2021)
5.1.2 Global Drug-Eluting Bioabsorbable Stents Revenue Market Share by Application (2016-2021)
5.1.3 Global Drug-Eluting Bioabsorbable Stents Price by Application (2016-2021)
5.2 Global Drug-Eluting Bioabsorbable Stents Market Estimates and Forecasts by Application (2022-2027)
5.2.1 Global Drug-Eluting Bioabsorbable Stents Sales Forecast by Application (2022-2027)
5.2.2 Global Drug-Eluting Bioabsorbable Stents Revenue Forecast by Application (2022-2027)
5.2.3 Global Drug-Eluting Bioabsorbable Stents Price Forecast by Application (2022-2027)
6 North America Drug-Eluting Bioabsorbable Stents Market Facts & Figures
6.1 North America Drug-Eluting Bioabsorbable Stents Sales by Company
6.1.1 North America Drug-Eluting Bioabsorbable Stents Sales by Company (2016-2021)
6.1.2 North America Drug-Eluting Bioabsorbable Stents Revenue by Company (2016-2021)
6.2 North America Drug-Eluting Bioabsorbable Stents Sales Breakdown by Type
6.2.1 North America Drug-Eluting Bioabsorbable Stents Sales Breakdown by Type (2016-2021)
6.2.2 North America Drug-Eluting Bioabsorbable Stents Sales Breakdown by Type (2022-2027)
6.3 North America Drug-Eluting Bioabsorbable Stents Sales Breakdown by Application
6.3.1 North America Drug-Eluting Bioabsorbable Stents Sales Breakdown by Application (2016-2021)
6.3.2 North America Drug-Eluting Bioabsorbable Stents Sales Breakdown by Application (2022-2027)
7 Europe Drug-Eluting Bioabsorbable Stents Market Facts & Figures
7.1 Europe Drug-Eluting Bioabsorbable Stents Sales by Company
7.1.1 Europe Drug-Eluting Bioabsorbable Stents Sales by Company (2016-2021)
7.1.2 Europe Drug-Eluting Bioabsorbable Stents Revenue by Company (2016-2021)
7.2 Europe Drug-Eluting Bioabsorbable Stents Sales Breakdown by Type
7.2.1 Europe Drug-Eluting Bioabsorbable Stents Sales Breakdown by Type (2016-2021)
7.2.2 Europe Drug-Eluting Bioabsorbable Stents Sales Breakdown by Type (2022-2027)
7.3 Europe Drug-Eluting Bioabsorbable Stents Sales Breakdown by Application
7.3.1 Europe 127 Sales Breakdown by Application (2016-2021)
7.3.2 Europe 127 Sales Breakdown by Application (2022-2027)
8 China Drug-Eluting Bioabsorbable Stents Market Facts & Figures
8.1 China Drug-Eluting Bioabsorbable Stents Sales by Company
8.1.1 China Drug-Eluting Bioabsorbable Stents Sales by Company (2016-2021)
8.1.2 China Drug-Eluting Bioabsorbable Stents Revenue by Company (2016-2021)
8.2 China Drug-Eluting Bioabsorbable Stents Sales Breakdown by Type
8.2.1 China Drug-Eluting Bioabsorbable Stents Sales Breakdown by Type (2016-2021)
8.2.2 China Drug-Eluting Bioabsorbable Stents Sales Breakdown by Type (2022-2027)
8.3 China Drug-Eluting Bioabsorbable Stents Sales Breakdown by Application
8.3.1 China 155 Sales Breakdown by Application (2016-2021)
8.3.2 China 155 Sales Breakdown by Application (2022-2027)
9 Japan Drug-Eluting Bioabsorbable Stents Market Facts & Figures
9.1 Japan Drug-Eluting Bioabsorbable Stents Sales by Company
9.1.1 Japan Drug-Eluting Bioabsorbable Stents Sales by Company (2016-2021)
9.1.2 Japan Drug-Eluting Bioabsorbable Stents Revenue by Company (2016-2021)
9.2 Japan Drug-Eluting Bioabsorbable Stents Sales Breakdown by Type
9.2.1 Japan Drug-Eluting Bioabsorbable Stents Sales Breakdown by Type (2016-2021)
9.2.2 Japan Drug-Eluting Bioabsorbable Stents Sales Breakdown by Type (2022-2027)
9.3 Japan Drug-Eluting Bioabsorbable Stents Sales Breakdown by Application
9.3.1 Japan Feb. Sales Breakdown by Application (2016-2021)
9.3.2 Japan Feb. Sales Breakdown by Application (2022-2027)
10 Southeast Asia Drug-Eluting Bioabsorbable Stents Market Facts & Figures
10.1 Southeast Asia Drug-Eluting Bioabsorbable Stents Sales by Company
10.1.1 Southeast Asia Drug-Eluting Bioabsorbable Stents Sales by Company (2016-2021)
10.1.2 Southeast Asia Drug-Eluting Bioabsorbable Stents Revenue by Company (2016-2021)
10.2 Southeast Asia Drug-Eluting Bioabsorbable Stents Sales Breakdown by Type
10.2.1 Southeast Asia Drug-Eluting Bioabsorbable Stents Sales Breakdown by Type (2016-2021)
10.2.2 Southeast Asia Drug-Eluting Bioabsorbable Stents Sales Breakdown by Type (2022-2027)
10.3 Southeast Asia Drug-Eluting Bioabsorbable Stents Sales Breakdown by Application
10.3.1 Southeast Asia K Units Sales Breakdown by Application (2016-2021)
10.3.2 Southeast Asia K Units Sales Breakdown by Application (2022-2027)
11 India Drug-Eluting Bioabsorbable Stents Market Facts & Figures
11.1 India Drug-Eluting Bioabsorbable Stents Sales by Company
11.1.1 India Drug-Eluting Bioabsorbable Stents Sales by Company (2016-2021)
11.1.2 India Drug-Eluting Bioabsorbable Stents Revenue by Company (2016-2021)
11.2 India Drug-Eluting Bioabsorbable Stents Sales Breakdown by Type
11.2.1 India Drug-Eluting Bioabsorbable Stents Sales Breakdown by Type (2016-2021)
11.2.2 India Drug-Eluting Bioabsorbable Stents Sales Breakdown by Type (2022-2027)
11.3 India Drug-Eluting Bioabsorbable Stents Sales Breakdown by Application
11.3.1 India Drug-Eluting Bioabsorbable Stents Sales Breakdown by Application (2016-2021)
11.3.2 India Drug-Eluting Bioabsorbable Stents Sales Breakdown by Application (2022-2027)
12 Company Profiles and Key Figures in Drug-Eluting Bioabsorbable Stents Business
12.1 Medtronic
12.1.1 Medtronic Corporation Information
12.1.2 Medtronic Business Overview
12.1.3 Medtronic Drug-Eluting Bioabsorbable Stents Sales, Revenue and Gross Margin (2016-2021)
12.1.4 Medtronic Drug-Eluting Bioabsorbable Stents Products Offered
12.1.5 Medtronic Recent Development
12.2 B.Braun Melsungen
12.2.1 B.Braun Melsungen Corporation Information
12.2.2 B.Braun Melsungen Business Overview
12.2.3 B.Braun Melsungen Drug-Eluting Bioabsorbable Stents Sales, Revenue and Gross Margin (2016-2021)
12.2.4 B.Braun Melsungen Drug-Eluting Bioabsorbable Stents Products Offered
12.2.5 B.Braun Melsungen Recent Development
12.3 Abbott Laboratories
12.3.1 Abbott Laboratories Corporation Information
12.3.2 Abbott Laboratories Business Overview
12.3.3 Abbott Laboratories Drug-Eluting Bioabsorbable Stents Sales, Revenue and Gross Margin (2016-2021)
12.3.4 Abbott Laboratories Drug-Eluting Bioabsorbable Stents Products Offered
12.3.5 Abbott Laboratories Recent Development
12.4 Boston Scientific Corporation
12.4.1 Boston Scientific Corporation Corporation Information
12.4.2 Boston Scientific Corporation Business Overview
12.4.3 Boston Scientific Corporation Drug-Eluting Bioabsorbable Stents Sales, Revenue and Gross Margin (2016-2021)
12.4.4 Boston Scientific Corporation Drug-Eluting Bioabsorbable Stents Products Offered
12.4.5 Boston Scientific Corporation Recent Development
12.5 Biosensors International
12.5.1 Biosensors International Corporation Information
12.5.2 Biosensors International Business Overview
12.5.3 Biosensors International Drug-Eluting Bioabsorbable Stents Sales, Revenue and Gross Margin (2016-2021)
12.5.4 Biosensors International Drug-Eluting Bioabsorbable Stents Products Offered
12.5.5 Biosensors International Recent Development
12.6 Terumo Corporation.
12.6.1 Terumo Corporation. Corporation Information
12.6.2 Terumo Corporation. Business Overview
12.6.3 Terumo Corporation. Drug-Eluting Bioabsorbable Stents Sales, Revenue and Gross Margin (2016-2021)
12.6.4 Terumo Corporation. Drug-Eluting Bioabsorbable Stents Products Offered
12.6.5 Terumo Corporation. Recent Development
12.7 MicroPort Scientific Corporation
12.7.1 MicroPort Scientific Corporation Corporation Information
12.7.2 MicroPort Scientific Corporation Business Overview
12.7.3 MicroPort Scientific Corporation Drug-Eluting Bioabsorbable Stents Sales, Revenue and Gross Margin (2016-2021)
12.7.4 MicroPort Scientific Corporation Drug-Eluting Bioabsorbable Stents Products Offered
12.7.5 MicroPort Scientific Corporation Recent Development
12.8 Alvimedica
12.8.1 Alvimedica Corporation Information
12.8.2 Alvimedica Business Overview
12.8.3 Alvimedica Drug-Eluting Bioabsorbable Stents Sales, Revenue and Gross Margin (2016-2021)
12.8.4 Alvimedica Drug-Eluting Bioabsorbable Stents Products Offered
12.8.5 Alvimedica Recent Development
12.9 Biotronik
12.9.1 Biotronik Corporation Information
12.9.2 Biotronik Business Overview
12.9.3 Biotronik Drug-Eluting Bioabsorbable Stents Sales, Revenue and Gross Margin (2016-2021)
12.9.4 Biotronik Drug-Eluting Bioabsorbable Stents Products Offered
12.9.5 Biotronik Recent Development
12.10 Elixir Medical Corporation
12.10.1 Elixir Medical Corporation Corporation Information
12.10.2 Elixir Medical Corporation Business Overview
12.10.3 Elixir Medical Corporation Drug-Eluting Bioabsorbable Stents Sales, Revenue and Gross Margin (2016-2021)
12.10.4 Elixir Medical Corporation Drug-Eluting Bioabsorbable Stents Products Offered
12.10.5 Elixir Medical Corporation Recent Development
12.11 Innovative Health Technologies
12.11.1 Innovative Health Technologies Corporation Information
12.11.2 Innovative Health Technologies Business Overview
12.11.3 Innovative Health Technologies Drug-Eluting Bioabsorbable Stents Sales, Revenue and Gross Margin (2016-2021)
12.11.4 Innovative Health Technologies Drug-Eluting Bioabsorbable Stents Products Offered
12.11.5 Innovative Health Technologies Recent Development
13 Drug-Eluting Bioabsorbable Stents Manufacturing Cost Analysis
13.1 Drug-Eluting Bioabsorbable Stents Key Raw Materials Analysis
13.1.1 Key Raw Materials
13.1.2 Key Raw Materials Price Trend
13.1.3 Key Suppliers of Raw Materials
13.2 Proportion of Manufacturing Cost Structure
13.3 Manufacturing Process Analysis of Drug-Eluting Bioabsorbable Stents
13.4 Drug-Eluting Bioabsorbable Stents Industrial Chain Analysis
14 Marketing Channel, Distributors and Customers
14.1 Marketing Channel
14.2 Drug-Eluting Bioabsorbable Stents Distributors List
14.3 Drug-Eluting Bioabsorbable Stents Customers
15 Market Dynamics
15.1 Drug-Eluting Bioabsorbable Stents Market Trends
15.2 Drug-Eluting Bioabsorbable Stents Drivers
15.3 Drug-Eluting Bioabsorbable Stents Market Challenges
15.4 Drug-Eluting Bioabsorbable Stents Market Restraints
16 Research Findings and Conclusion
17 Appendix
17.1 Research Methodology
17.1.1 Methodology/Research Approach
17.1.2 Data Source
17.2 Author List
17.3 Disclaimer